BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 35349173)

  • 21. From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach.
    Rojewska P; Meczekalski B; Bala G; Luisi S; Podfigurna A
    Gynecol Endocrinol; 2022 Jul; 38(7):537-542. PubMed ID: 35647677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgens in Cushing's Syndrome.
    Arnaldi G; Martino M
    Front Horm Res; 2019; 53():77-91. PubMed ID: 31499501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Successive Pharmacologic Hormone Suppression Testing for a Severe Presentation of Adolescent Polycystic Ovarian Syndrome: A Case Report.
    Ravi SJ; Cree-Green M
    J Investig Med High Impact Case Rep; 2019; 7():2324709619850215. PubMed ID: 31113263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma.
    Dennedy MC; Smith D; O'Shea D; McKenna TJ
    Eur J Endocrinol; 2010 Feb; 162(2):213-20. PubMed ID: 19906851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
    Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
    Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
    Bidzińska B; Tworowska U; Demissie M; Milewicz A
    Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperandrogenism: clinical aspects, investigation and treatment].
    Beckers A; Parotte MC; Gaspard U; Khalife A
    Rev Med Liege; 1999 Apr; 54(4):274-82. PubMed ID: 10389470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperandrogenism and Its Possible Effects on Endometrial Receptivity: A Review.
    Yusuf ANM; Amri MF; Ugusman A; Hamid AA; Wahab NA; Mokhtar MH
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiating Polycystic Ovary Syndrome from Adrenal Disorders.
    Yesiladali M; Yazici MGK; Attar E; Kelestimur F
    Diagnostics (Basel); 2022 Aug; 12(9):. PubMed ID: 36140452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of hyperandrogenism: clinical criteria.
    Yildiz BO
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):167-76. PubMed ID: 16772149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
    Waggoner W; Boots LR; Azziz R
    Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. II.
    Sperling LC; Heimer WL
    J Am Acad Dermatol; 1993 Jun; 28(6):901-16. PubMed ID: 8496453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors.
    Sanchón R; Gambineri A; Alpañés M; Martínez-García MÁ; Pasquali R; Escobar-Morreale HF
    Hum Reprod; 2012 Apr; 27(4):1209-16. PubMed ID: 22343706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A practical approach to the diagnosis of polycystic ovary syndrome.
    Chang RJ
    Am J Obstet Gynecol; 2004 Sep; 191(3):713-7. PubMed ID: 15467530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovary syndrome and acne.
    Chuan SS; Chang RJ
    Skin Therapy Lett; 2010; 15(10):1-4. PubMed ID: 21076799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hirsutism in women.
    Bode D; Seehusen DA; Baird D
    Am Fam Physician; 2012 Feb; 85(4):373-80. PubMed ID: 22335316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation and treatment of adolescent girls with hirsutism].
    Bumbuliene Z; Alisauskas J
    Ginekol Pol; 2009 May; 80(5):374-8. PubMed ID: 19548458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen excess: Investigations and management.
    Lizneva D; Gavrilova-Jordan L; Walker W; Azziz R
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():98-118. PubMed ID: 27387253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrinology of Hirsutism: From Androgens to Androgen Excess Disorders.
    Yilmaz B; Yildiz BO
    Front Horm Res; 2019; 53():108-119. PubMed ID: 31499500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.